The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): Report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities

Cardiovascular Pathology

Volumn 48, Issue , 2020, Pages

  Buja, Louis Maximilian ^a   Wolf, Dwayne ^b   Zhao, Bihong ^a   Akkanti, Bindu ^a,c   McDonald, Michelle ^a   Lelenwa, Laura ^a   Reilly, Noah ^a   Ottaviani, Giulia ^e   Elghetany, M Tarek ^f   Trujillo, Daniel Ocazionez ^a   Aisenberg, Gabriel M ^c,d   Madjid, Mohammad ^c   Kar, Biswajit ^a,c  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b Harris County Institute of Forensic Sciences   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d Lyndon B Johnson General Hospital   (United States)

^e UNIVERSITY OF MILAN   (Italy)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Autopsy; Coagulopathy; COVID 19; Diffuse alveolar damage; Heart; Kidney; Liver; SARS CoV 2; Spleen; Viral pneumonia

Indexed keywords

FIBRIN; PROCOAGULANT;

ARTICLE; AUTOPSY; BLOOD CLOTTING DISORDER; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CHINA; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; CORONAVIRUS DISEASE 2019; FIBRIN DEPOSITION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE INJURY; HISTOPATHOLOGY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; INTERSTITIAL PNEUMONIA; LUNG ARTERIOLE; LUNG DISEASE; LUNG EMBOLISM; LUNG HEMORRHAGE; LUNG INFARCTION; LYMPHOCYTIC MYOCARDITIS; MICROTHROMBUS; MYOCARDITIS; NEUTROPHIL; ORGANIZING PNEUMONIA; PERICARDITIS; PRIORITY JOURNAL; PUBLICATION; RESPIRATORY SYSTEM; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SYSTEMIC DISEASE; TEXAS; THROMBOEMBOLISM; UNITED STATES; VIRUS PNEUMONIA; ADULT; AGED; BETACORONAVIRUS; CARDIAC MUSCLE; CAUSE OF DEATH; COMORBIDITY; COMPLICATION; CORONAVIRUS INFECTION; EPIDEMIOLOGY; FEMALE; HEALTH STATUS; HEART; HEART DISEASE; HOST PATHOGEN INTERACTION; LUNG; MALE; MIDDLE AGED; MORTALITY; PANDEMIC; PATHOGENICITY; PATHOLOGY; RISK FACTOR; VERY ELDERLY; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; BETACORONAVIRUS; CAUSE OF DEATH; COMORBIDITY; CORONAVIRUS INFECTIONS; FEMALE; HEALTH STATUS; HEART; HEART DISEASES; HOST-PATHOGEN INTERACTIONS; HUMANS; LUNG; MALE; MIDDLE AGED; MYOCARDIUM; PANDEMICS; PNEUMONIA, VIRAL; RISK FACTORS; UNITED STATES;

EID: 85084684792     PISSN: 10548807     EISSN: 18791336     Source Type: Journal    
DOI: 10.1016/j.carpath.2020.107233     Document Type: Article

References (99)

1. Wuhan Municipal Health Commission. [Report of clustering pneumonia of unknown etiology in Wuhan City] (In Chinese). Available at: http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989; 2019Accessed April 15, 2020.
2. World Health Organization (WHO). Pneumonia of unknown cause – China2020. Available at: https://www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-china/en/; Accessed April 15, 2020.
3. Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382:8 (2020), 727–733, 10.1056/NEJMoa2001017.
4. Scherer, A., Genetic analysis of the covid-19 virus and other pathogens. 2020, Golden Helix Available at https://www.goldenhelix.com/resources/ebooks/genetic-analysis-covid-19-other-pathogens.html Accessed April 15, 2020.
5. Guan, W.J., Ni, Z.Y., Hu, Y., Liang, W.H., Ou, C.Q., He, J.X., et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 382:18 (2020), 1708–1720, 10.1056/NEJMoa2002032.
6. Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel corona virus pneumonia in Wuhan, China: a descriptive study. Lancet 395:10223 (2020), 507–513, 10.1016/S0140-6736(20)30211-7.
7. Xu, X., Barth, R.F., Buja, L.M, A call for action: the need for autopsies to determine the full extent of organ involvement associated with COVID-19 infection. Chest, 2020, 10.1016/j.chest.2020.03.060 Apr 10 [Epub ahead of print].
8. Buja, L.M., Barth, R.F., Krueger, G.R., Brodsky, S.V., Hunter, R.L, The importance of the autopsy in Medicine: perspectives of pathology colleagues. Acad Pathol, 6, 2019, 2374289519834041, 10.1177/2374289519834041.
9. Occupational Safety and Health Administration (OSHA)Available at: https://www.osha.gov/Publications/OSHA3990.pdf; 2020Accessed April 15, 2020.
10. Centers for Disease Control and Prevention (CDC). Collection and submission of postmortem specimens from deceased persons with known or suspected COVID-19, march 2020 (Interim guidance). 2020 Available at https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-postmortem-specimens.html Accessed April 15, 2020.
11. P.A. Harris, MD, MA, President, American Medical Association. Defending science in a time of fear and uncertainty. Available at: https://www.ama-assn.org/about/leadership/defending-science-time-fear-and-uncertainty?utm_source=BulletinHealtcare&utm_medium=email&utm_term=041120&utm-content=physicians&utm; 2020Accessed April 15, 2020.
12. Liu, Q., Wang, R.S., Qu, G.Q., Wang, Y.Y., Liu, P., Zhu, Y.Z., et al. Gross examination report of a COVID-19 death autopsy. Fa Yi Xue Za Zhi 36:1 (2020), 21–23, 10.12116/j.issn.1004-5619.2020.01.005.
13. Xu, Z., Shi, L., Wang, Y., Huang, L., Zhang, C., Liu, S., et al. Pathological findings of COVID-19 associated respiratory distress syndrome. Lancet Respir Med, 2020, 10.1016/S2213-2600(20)3006-X.
14. Tian, S., Hu, W., Niu, L., Liu, H., Xu, H., Xiao, S.Y, Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol, 2020, 10.1016/j.jtho.2020.02.010 [Epub ahead of print].
15. Barton, L.M., Duval, E.J., Stroberg, E., Ghosh, S., Mukhopadhyay, S, COVID-19 autopsies, Oklahoma, USA. Am J Clin Pathol, 2020, 10.1093/ajcp/aqaa062 XX1-9.
16. Fox, S.E., Akmatbekov, A., Harbert, J.L., Li, G., Brown, J.Q., Vander Heide, R.S, Pulmonary and cardiac pathology in COVID-19: the first autopsy series from New Orleans. MedRxiv, 2020 Available at https://doi.org/10.1101/2020.04.06.20050575 Accessed April 15, 2020.
17. Bradley B.T., Maioli H., Johnson R., Chaudhry I., Fink S.L., Xu H., Najafian B., Marshall D., Lacy J.M., Williams T., Yarid N. Histopathology and ultrastructural findings of fatal COVID-19 infections. MedRxiv.Available at: https://www.medrxiv.org/content/10.1101/2020.04.17.20058545v1. Posted April 21, 2020.
18. Grimes, Z., Bryce, C., Sordillo, E.M., Gordon, R.E., Reidy, J., Paniz Mondolfi, A., Fowkes, M., Fatal pulmonary thromboembolism in SARS-CoV-2-infection. Cardiovasc Pathol, 2020 In press.
19. Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study [published online ahead of print, 2020 Feb 24] [published correction appears in Lancet Respir Med. 2020 Apr;8(4):e26]. Lancet Respir Med, 2020, 10.1016/S2213-2600(20)30079-5.
20. Ruan, Q., Yang, K., Wang, W., Jiang, L., Song, J, Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China [published online ahead of print, 2020 Mar 3] [published correction appears in Intensive Care Med 2020 Apr 6]. Intensive Care Med, 2020, 1–3, 10.1007/s00134-020-05991-x.
21. Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study [published correction appears in Lancet. 2020 Mar 28;395(10229):1038] [published correction appears in Lancet. 2020 Mar 28;395(10229):1038]. Lancet 395:10229 (2020), 1054–1062, 10.1016/S0140-6736(20)30566-3.
22. Guo, W., Li, M., Dong, Y., Zhou, H., Zhang, Z., Tian, C., et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev, 2020, e3319, 10.1002/dmrr.3319 [Epub ahead of print].
23. Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest., 2020, 137244, 10.1172/JCI137244 [Epub ahead of print].
24. Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., et al. Risk Factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med, 2020, e200994, 10.1001/jamainternmed.2020.0994 [Epub ahead of print].
25. Qiu, H., Wu, J., Hong, L., Luo, Y., Song, Q., Chen, D, Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study. Lancet Infect Dis, 2020, 10.1016/S1473-3099(20)30198-5 S1473-3099(20)30198-5 [Epub ahead of print].
26. Zhang, J.J., Dong, X., Cao, Y.Y., Yuan, Y.D., Yang, Y.B., Yan, Y.Q., et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy, 2020, 10.1111/all.14238 [Epub ahead of print]. DOI:2020;10.1111/all.14238.
27. Richardson, S., Hirsch, J.S., Narasimhan, M., Crawford, J.M., McGinn, T., Davidson, K.W., et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area [published online ahead of print, 2020 Apr 22]. JAMA, 2020, 10.1001/jama.2020.6775 10.1001/jama.2020.6775.
28. Henry, B.M., de Oliveira, M.H.S., Benoit, S., Plebani, M., Lippi, G, Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis [published online ahead of print, 2020 Apr 10]. Clin Chem Lab Med, 2020, 10.1515/cclm-2020-0369 /j/cclm.ahead-of-print/cclm-2020-0369/cclm-2020-0369.xml.
29. Geng, Y.-.J., Wei, Z.-.Y., Qian, H.-.Y., Huang, J., Lodato, R., Castriotta, R, Pathopysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019. Cardiovasc Pathol, 2020 In press.
30. Madjid, M., Safavi-Naeini, P., Solomon, S.D., Vardeny, O, Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol, 2020, 10.1001/jamacardio.2020.1286 10.1001/jamacardio.2020.1286 [Epub ahead of print].
31. Akhmerov, A., Marban, E., COVID-19 and the Heart [published online ahead of print, 2020 Apr 7]. Circ Res, 2020, 10.1161/CIRCRESAHA.120.317055 10.1161/CIRCRESAHA.120.317055.
32. Cheung, O.Y., Graziano, P., Smith, M.L, Acute lung injury. Leslie, KO, Wick, MR, (eds.) Practical pulmonary pathology: a diagnostic approach, 2nd edition, 2018, Elsevier Saunders, Philadelphia, 125–146.
33. Tomashefski, J.F. Jr, Pulmonary pathology of acute respiratory distress syndrome. Clin Chest Med 21:3 (2000), 435–466, 10.1016/s0272-5231(05)70158-1.
34. Mandal, R.V., Mark, E.J., Kradin, R.L., Megakaryocytes and platelet homeostasis in diffuse alveolar damage. Exp Mol Pathol 83:3 (2007), 327–331, 10.1016/j.yexmp.2007.08.005.
35. Beasley, M.B., Franks, T.J., Galvin, J.R., Gochuico, B., Travis, W.D, Acute fibrinous and organizing pneumonia: a histological pattern of lung injury and possible variant of diffuse alveolar damage. Arch Pathol Lab Med 126:9 (2002), 1064–1070, 10.1043/0003-9985(2002)126<1064:AFAOP>2.0.CO;2.
36. Copin, M.C., Parmentier, E., Duburcq, T., Poissy, J., Mathieu, D., Lille COVID-19 ICU and Anatomopathology Group. Time to consider histologic pattern of lung injury to treat critically ill patients with COVID-19 infection [published online ahead of print, 2020 Apr 23]. Intensive Care Med, 2020, 1–3, 10.1007/s00134-020-06057-8.
37. Hwang, D.M., Chamberlain, D.W., Poutanen, S.M., Low, D.E., Asa, S.L., Butany, J, Pulmonary pathology of severe acute respiratory syndrome in Toronto. Mod Pathol 18:1 (2005), 1–10, 10.1038/modpathol.3800247.
38. Gu, J., Korteweg, C., Pathology and pathogenesis of severe acute respiratory syndrome. Am J Pathol 170:4 (2007), 1136–1147, 10.2353/ajpath.2007.061088.
39. Buja, L.M., Zehr, B., Lelenwa, L., Ogechukwu, E., Zhao, B., Dasgupta, A., et al. Clinicopathological complexity in the application of the universal definition of myocardial infarction. Cardiovasc Pathol, 44, 2020, 107153, 10.1016/j.carpath.2019.107153.
40. Buja, L.M., Ottaviani, G., Ilic, M., Zhao, B., Lelenwa, L.C., Segura, A.M., et al. Clinicopathological manifestations of myocarditis in a heart failure population. Cardiovasc Pathol, 45, 2020, 107190, 10.1016/j.carpath.2019.107190.
41. Bularga, A., Lee, K.K., Stewart, S., Ferry, A.M., Chapman, A.R., Marshall, L., et al. High-sensitivity troponin and the application of risk stratification thresholds in patients with suspected acute coronary syndrome. Circulation 140:19 (2019), 1557–1568, 10.1161/CIRCULATIONAHA.119.042866.
42. Lippi, G., Lavie, C.J., Sanchis-Gomar, F, Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis. Prog Cardiovasc Dis, 2020, 10.1016/j.pcad.2020.03.001 [Epub ahead of print].
43. Chapman, A.R., Bularga, A., Mills, N.L, High-sensitivity cardiac troponin can be an ally in the fight against COVID-19. Circulation, 2020, 10.1161/CIRCULATIONAHA.120.047008 10.1161/CIRCULATIONAHA.120.047008 [Epub ahead of print].
44. Du, Y., Tu, L., Zhu, P., Mu, M., Wang, R., Yang, P., et al. Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan: A Retrospective Observational Study. Am J Respir Crit Care Med, 2020, 10.1164/rccm.202003-0543O 10.1164/rccm.202003-0543OC.
45. Tetro, J.A., Is COVID-19 receiving ADE from other coronaviruses?. Microbes Infect 22:2 (2020), 72–73, 10.1016/j.micinf.2020.02.006.
46. Sharma, A., It is too soon to attribute ADE to COVID-19. Microbes Infect, 2020, 10.1016/j.micinf.2020.03.005 pii: S1286-4579(20)30051-4[Epub ahead of print]. doi: 10.1016/j.micinf.2020.03.
47. Bai, H.X., Hsieh, B., Xiong, Z., Halsey, K., Choi, J.W., Tran, T.M.L., Pan, I., Shi, L.B., Wang, D.C., Mei, J., Jiang, X.L., Zeng, Q.H., Egglin, T.K., Hu, P.F., Agarwal, S., Xie, F., Li, S., Healey, T., Atalay, M.K., Liao, W.H., Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT. Radiology, 10, 2020, 200823, 10.1148/radiol.2020200823 [Epub ahead of print].
48. Chung, M., Bernheim, A., Mei, X., Zhang, N., Huang, M., Zeng, X., Cui, J., Xu, W., Yang, Y., Fayad, Z.A., Jacobi, A, Li, K., Li, S., Shan, H., CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV). Radiology 295:1 (2020), 202–207, 10.1148/radiol.2020200230.
49. Simpson, S., Kay, F., Abbara, S., Bhalla, S., Chung, J.H., Chung, M., et al. Radiological society of north America expert consensus statement on reporting chest CT findings related to COVID-19. Endorsed by the society of thoracic radiology, the American college of radiology, and RSNA. J Thorac Imaging, 2020, 10.1097/RTI.0000000000000524 10.1097/RTI.0000000000000524.
50. Torrealba, J.R., Fisher, S., Kanne, J.P., Butt, Y.M., Glazer, C., Kershaw, C., et al. Pathology-radiology correlation of common and uncommon computed tomographic patterns of organizing pneumonia. Hum Pathol 71 (2018), 30–40, 10.1016/j.humpath.2017.10.028.
51. Ruuskanen, O., Lahti, E., Jennings, L.C., Murdoch, D.R, Viral pneumonia. Lancet 377:9773 (2011), 1264–1275, 10.1016/S0140-6736(10)61459-6.
52. Ishiguro, T., Takayanagi, N., Kanauchi, T., Uozumi, R., Kawate, E., Takaku, Y., et al. Clinical and radiographic comparison of influenza virus-associated pneumonia among three viral subtypes. Intern Med 55:7 (2016), 731–737, 10.2169/internalmedicine.55.5227.
53. Castro, C.Y, ARDS and diffuse alveolar damage: a pathologist's perspective. Semin Thorac Cardiovasc Surg 18:1 (2006), 13–19, 10.1053/j.semtcvs.2006.02.001.
54. Cardinal-Fernández, P., Lorente, J.A., Ballén-Barragán, A., Matute-Bello, G, Acute respiratory distress syndrome and diffuse alveolar damage. New insights on a complex relationship. Ann Am Thorac Soc 14:6 (2017), 844–850, 10.1513/AnnalsATS.201609-728PS.
55. Song, C., Li, H., Li, Y., Dai, M., Zhang, L., Liu, S., et al. NETs promote ALI/ARDS inflammation by regulating alveolar macrophage polarization. Exp Cell Res, 382(2), 2019, 111486, 10.1016/j.yexcr.2019.06.031.
56. Morrell, E.D., Bhatraju, P.K., Mikacenic, C.R., Radella 2nd, F., Manicone, A.M., Stapleton, R.D., et al. Alveolar macrophage transcriptional programs are associated with outcomes in acute respiratory distress syndrome. Am J Respir Crit Care Med 200:6 (2019), 732–741, 10.1164/rccm.201807-1381OC.
57. Xiong, Y., Liu, Y., Cao, L., Wang, D., Guo, M., Jiang, A., et al. Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients. Emerg Microbes Infect 9:1 (2020), 761–770, 10.1080/22221751.2020.1747363.
58. Lumb, A.B., Slinger, P., Hypoxic pulmonary vasoconstriction: physiology and anesthetic implications. Anesthesiology 122:4 (2015), 932–946, 10.1097/ALN.0000000000000569.
59. Hashisako, M., Fukuoka, J., Smith, M.L, Chronic diffuse lung diseases. Leslie, KO, Wick, MR, (eds.) Practical pulmonary pathology: a diagnostic approach, 2nd edition, 2018, Elsevier Saunders, Philadelphia, 227–298.
60. Bansal, M., Cardiovascular disease and COVID-19. Diabetes Metab Syndr 14:3 (2020), 247–250, 10.1016/j.dsx.2020.03.013 [Epub ahead of print].
61. Guo, T., Fan, Y., Chen, M., Wu, X., Zhang, L., He, T., et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol, 2020, e201017, 10.1001/jamacardio.2020.1017 [Epub ahead of print].
62. Tam, C.F., Cheung, K.S., Lam, S., Wong, A., Yung, A., Sze, M., et al. Impact of coronavirus disease 2019 (COVID-19) outbreak on ST-segment-elevation myocardial infarction care in Hong Kong, China. Circ Cardiovasc Qual Outcomes, 2020, 10.1161/CIRCOUTCOMES.120.006631 CIRCOUTCOMES120006631.
63. He, X.W., Lai, J.S., Cheng, J., Wang, M.W., Liu, Y.J., Xiao, Z.C., et al. [Impact of complicated myocardial injury on the clinical outcome of severe or critically ill COVID-19 patients]. Zhonghua Xin Xue Guan Bing Za Zhi, 48(0), 2020, E011, 10.3760/cma.j.cn112148-20200228-00137 (In Chinese with English Abstract).
64. Inciardi, R.M., Lupi, L., Zaccone, G., Italia, L., Raffo, M., Tomasoni, D., et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol, 2020, 10.1001/jamacardio.2020.1096 10.1001/jamacardio.2020.1096 [Epub ahead of print].
65. Tavazzi, G., Pellegrini, C., Maurelli, M., Belliato, M., Sciutti, F., Bottazzi, A., et al. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail, 2020, 10.1002/ejhf.1828 10.1002/ejhf.1828 [Epub ahead of print].
66. Afzelius, B.A., Ultrastructure of human nasal epithelium during an episode of coronavirus infection. Virchows Arch 424:3 (1994), 295–300, 10.1007/bf00194614.
67. Chen, L., Li, X., Chen, M., Feng, Y., Xiong, C, The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res, 2020, cvaa078, 10.1093/cvr/cvaa078 [Epub ahead of print].
68. Madjid, M., Vela, D., Khalili-Tabrizi, H., Casscells, S.W., Litovsky, S, Systemic infections cause exaggerated local inflammation in atherosclerotic coronary arteries: clues to the triggering effect of acute infections on acute coronary syndromes. Tex Heart Inst J 34:1 (2007), 11–18.
69. Wybraniec, M., Mizia-Stec, K., Krzych, L, Stress cardiomyopathy: yet another type of neurocardiogenic injury: 'stress cardiomyopathy'. Cardiovasc Pathol 23:3 (2014), 113–120, 10.1016/j.carpath.2013.12.003.
70. Ahmadjee, A., Herzallah, K., Saleh, Y., Abela, G.S, Takotsubo Cardiomyopathy presenting with different morphological patterns in the same patient: a case report and review of the literature [published online ahead of print, 2020 Jan 15]. Cardiovasc Pathol, 47, 2020, 107204, 10.1016/j.carpath.2020.107204.
71. Aslam, S., Mehra, M.R., COVID-19: yet another coronavirus challenge in transplantation. J Heart Lung Transplant, 2020, 10.1016/j.healun.2020.03.007 S1053-2498(20)31468-6 [Epub ahead of print].
72. Vejpongsa, P., Kitkungvan, D., Madjid, M., Charitakis, K., Anderson, H.V., Arian, S., et al. Outcomes of acute myocardial infarction in patients with influenza and other viral respiratory infections. Am J Med 132:10 (2019), 1173–1181, 10.1016/j.amjmed.2019.05.002.
73. Madjid, M., Aboshady, I., Awan, I., Litovsky, S., Casscells, S.W, Influenza and cardiovascular disease: is there a causal relationship?. Tex Heart Inst J 31:1 (2004), 4–13.
74. Li, Y.C., Bai, W.Z., Hashikawa, T, The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol, 2020, 10.1002/jmv.25728 10.1002/jmv.25728 [Epub ahead of print].
75. Paniz-Mondolfi, A., Bryce, C., Grimes, Z., Gordon, R., Reidy, J., Lednicky, J., et al. Central nervous system involvement by severe acute respiratory syndrome coronavirus -2 (SARS-CoV-2). J Med Virol, 2020, 10.1002/jmv.25915 10.1002/jmv.25915.
76. Oxley, T.J., Mocco, J., Majidi, S., Kellner, C.P., Shoirah, H., Sing, P., et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med, 2020, 10.1056/NEJMc2009787 10.1056/NEJMc2009787.
77. Xu, L., Liu, J., Lu, M., Yang, D., Zheng, X, Liver injury during highly pathogenic human coronavirus infections. Liver Int, 2020, 10.1111/liv.14435 [Epub ahead of print].
78. Su, H., Yang, M., Wan, C., Yi, L.X., Tang, F., Zhu, H.Y., et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int., 2020, 10.1016/j.kint.2020.04.003.
79. Pei, G., Zhang, Z., Peng, J., Liu, L., Zhang, C., Yu, C., et al. Renal involvement and early prognosis in patients with COVID- 19 pneumonia. J Am Soc Nephrol, 2020, 10.1681/ASN.2020030276 ASN.2020030276.
80. Cheng, Y., Luo, R., Wang, K., Zhang, M., Wang, Z., Dong, L., et al. Kidney disease is associated with in-hospital death ofpatients with COVID-19. Kidney Int 97:5 (2020), 829–838, 10.1016/j.kint.2020.03.005.
81. Han, M., Yan, W., Huang, Y., Yao, H., Wang, Z., Xi, D., et al. The nucleocapsid protein of SARS-CoV induces transcription of hfgl2 prothrombinase gene dependent on C/EBP alpha. J Biochem 144:1 (2008), 51–62, 10.1093/jb/mvn042.
82. Chang, J.C., TTP-like syndrome: novel concept and molecular pathogenesis of endotheliopathy-associated vascular microthrombotic disease. Thromb J, 16, 2018, 20, 10.1186/s12959-018-0174-4.
83. Chang, J.C, Sepsis and septic shock: endothelial molecular pathogenesis associated with vascular microthrombotic disease. Thromb J, 17, 2019, 10, 10.1186/s12959-019-0198-4.
84. Sarzi-Puttini, P., Giorgi, V., Sirotti, S., Marotto, D., Ardizzone, A., Rizzardin, G., et al. COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?. Clin Exp Rheumatol 38:2 (2020), 337–342.
85. Toh, C.H., Alhamdi, Y., Abrams, S.T, Current pathological and laboratory considerations in the diagnosis of disseminated intravascular coagulation [published correction appears in Ann Lab Med. 2017 Jan;37(1):95]. Ann Lab Med 36:6 (2016), 505–512, 10.3343/alm.2016.36.6.505.
86. Gorla, R., Erbel, R., Eagle, K.A., Bossone, E, Systemic inflammatory response syndromes in the era of interventional cardiology. Vascul Pharmacol, 2018, 10.1016/j.vph.2018.04.003 S1537-1891(18)30020-X [Epub ahead of print].
87. Varga Z., Flammer A.J., Steiger P., et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. doi: 10.1016/S0140-6736(20)30937-5.
88. Keller, T.T/, Mairuhu, A.T., de Kruif, M.D., Klein, S.K., Gerdes, V.E.A., ten Cate, H., et al. Infections and endothelial cells. Cardiovasc Res 60:1 (2003), 40–48, 10.1016/s0008-6363(03)00354-7.
89. Singh, S., Jindal, A.K., Pilania, R.K., Diagnosis of Kawasaki disease. Int J Rheum Dis 21:1 (2018), 36–44, 10.1111/1756-185X.13224.
90. Ascierto, P.A., Fox, B.A., Urba, W.J., Bifulco, C.B., Botti, G., Lugli, A., et al. Insights from immuno-oncology: the Society for Immunotherapy of Cancer statement on access to IL-6-targeting therapies for COVID-19. J Immunotherap Cancer, 2020 In press.
91. Bikdeli, B., Madhavan, M.V., Jimenez, D., et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. J Am Col Cardiol, 2020, 10.1016/j.jacc.2020.04.031.
92. Klok, F.A., Kruip, M.J.H.A., van der Meer, N.J.M, Arbous, M.S., Gommers, D., Kant, K.M., et al. Incidence of thrombotic complicationsin critically ill ICU patients with COVID-19. Thromb Res, 2020, 10.1016/j.thromres.2020.04.013 S0049-3848(20)30120-1.
93. Tang, N., Bai, H., Chen, X., Gong, J., Li, D., Sun, Z, Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost, 2020, 10.1111/jth.14817 10.1111/jth.14817 [Epub ahead of print].
94. Thachil, J., The versatile heparin in COVID-19. J Thromb Haemost, 2020, 10.1111/jth.14821 10.1111/jth.14821 [Epub ahead of print].
95. Henry, B.M., COVID-19, ECMO, and lymphopenia: a word of caution. Lancet Respir Med, 8(4), 2020, e24, 10.1016/S2213-2600(20)30119-3.
96. Fedson, D.S., Opal, S.M., Rordam, O.M, Hiding in plain sight: an approach to treating patients with severe COVID-19 infection. MBio, 11(2), 2020, 10.1128/mBio.00398-20 e00398-20. Published 2020 Mar 20.
97. Patel, A.B., Verma, A., COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the rvidence? [published online ahead of print, 2020 Mar 24]. JAMA, 2020, 10.1001/jama.2020.4812 10.1001/jama.2020.4812.
98. Rossi, G.P., Sanga, V., Barton, M, Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients [published online ahead of print, 2020 Apr 6]. Elife, 9, 2020, e57278, 10.7554/eLife.57278.
99. Menter, T., Haslbauer, J.D., Nienhold, R., Savic, S., Hoper, H., Deigendesch, N., et al. Post-mortem examination of COVID19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings of lungs and other organs suggesting vascular dysfunction. Histopathology, 2020, 10.1111/his.14134 10.1111/his.14134.